Replies to post #334450 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

no you are really wrong

Not talking to me? that is a lame argument to shut someone up in an open discussion in an open forum don't you think? You can always send a message through PM here, other than that I respond to posts here thank you very much

Suit yourself. )

[biosectinvestor]

You are correct Gus. Anders is incorrect. It is best practice but commonly not possible to follow nor necessarily the best approach. Just generally thought to be “best practice” in terms of transparency.

Anders thinks things are black and white apparently, and leaves no room for the grays that basically dominate this entire field. The reality is that what might be labeled “bad”, on careful consideration might reveal an approvable blockbuster product in some cases. The reality is, data is data, not “bad or good”, and the management has discretion.

[Poor Man -]

I didn’t get the Gus wrong.

LOL. I wasn't talking to you, anders. I've read what you've posted. You can believe whatever you want. But, you are wrong. The cases you cited do not establish a hard and fast rule that a company has to disclose negative TLD via Form 8-K within 4 business days.

It's certainly "best practices" to release positive or negative TLD immediately. Like within a day or 2 at most. And for each day that passes, a company is more likely to have problems if the SEC initiates an enforcement action against them.

My main point is to put to bed the nonsense that somehow this investment has been derisked because the company hasn't issued a Form 8-K stating that the trial failed.